Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development
Go back to Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development| Actinium Pharmaceuticals, Inc. (NYSE: ATNM) | Delayed: 0.97 -0.08 (7.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.05 | 52 Week High | $3.50 | |||
| Open | $1.05 | 52 Week Low | $0.86 | |||
| Day High | $1.05 | P/E | N/A | |||
| Day Low | $0.96 | EPS | $-7.61 | |||
| Volume | 72,606 | |||||
| (NASDAQ: CNTA) | Delayed: 40.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.50 | 52 Week High | $ | |||
| Open | $40.50 | 52 Week Low | $ | |||
| Day High | $40.50 | P/E | N/A | |||
| Day Low | $40.50 | EPS | $ | |||
| Volume | 145 | |||||
| ISHARES SILVER TRUST (NYSE: SLV) | Delayed: 52.83 -1.63 (2.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.46 | 52 Week High | $19.71 | |||
| Open | $52.76 | 52 Week Low | $13.04 | |||
| Day High | $53.09 | P/E | N/A | |||
| Day Low | $51.72 | EPS | $0.00 | |||
| Volume | 20,076,048 | |||||
